Apixaban may be available through a mail-order pharmacy. Using this type of service may help lower the drug’s cost and allow you to receive your medication without leaving home.

Apixaban was also associated with fewer major hemorrhagic events, including stroke, when compared with warfarin. “Having some evidence to guide the decision-making when choosing between available ...

Rivaroxaban (Xarelto) was also associated with higher risk than apixaban (42.94 vs 20.05 per 1,000 person-years, HR 2.15, 95% ...

Key takeaways: Apixaban tied to less stroke and bleeding in patients with/without dementia vs. dabigatran, rivaroxaban or warfarin. This association was strongest for the outcome of major bleeding.

The primary endpoint, the composite of death or symptomatic recurrent VTE, was significantly reduced in the apixaban groups, from 11.6% in the placebo group to 3.8% in the low-dose apixaban and 4. ...

The European Committee for Medicinal Products for Human Use (CHMP) has recommended approval for apixaban (Eliquis, Pfizer and BristolMyers Squibb) for atrial fibrillation (AF). The drug is already ...

The trial enrolled patients with cryptogenic stroke and evidence suggestive of atrial cardiopathy, but no evidence of atrial fibrillation, who were randomized to apixaban, 5 mg or 2.5 mg twice ...

Apixaban is an anticoagulant drug, which is used for treating venous thromboembolic events and further research is needed for drug metabolism. About Careers Internship MedBlog Contact us English (US) ...

Bleeding risk does not appear to increase when apixaban is given concomitantly with cardiac P-glycoprotein (P-gp) inhibitors, according to research presented at the 2017 American Heart Association ...

Anticoagulation with apixaban after cryptogenic stroke with evidence of atrial cardiopathy and no atrial fibrillation did not prevent recurrent stroke compared with aspirin, researchers reported ...

Rivaroxaban (Xarelto) was also associated with higher risk than apixaban (42.94 vs 20.05 per 1,000 person-years, HR 2.15, 95% CI 1.18-3.94), again with a stronger association in those using ART ...